TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BMRN

Biomarin Pharmaceutical Inc

Healthcare · Biotechnology

63.90$ -1.8% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Biomarin Pharmaceutical Inc (BMRN): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/26/2026.

Next report 10/26/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 23 · -4.2 % 23 Q4 23 · -21.7 % 23 Q1 24 · 18.3 % 24 Q2 24 · 60.0 % 24 Q3 24 · 5.8 % 24 Q4 24 · 24.6 % 24 Q1 25 · 19.0 % 25 Q2 25 · 39.8 % 25 Q3 25 · -64.7 % 25 Q4 25 · -43.5 % 25 Q1 26 · -16.5 % 26 Q2 26 · 13.9 % 26

EPS estimate beaten

Full history 65 of 107 quarters (61%)
Last 16 quarters 11 of 16 quarters (69%)

Earnings Call Transcripts

Search all transcripts →

  • 05/04/2026 Earnings Call Q1 2026 Open →
  • 02/23/2026 Earnings Call Q4 2025 Open →
  • 10/27/2025 Earnings Call Q3 2025 Open →
  • 08/04/2025 Earnings Call Q2 2025 Open →
  • 05/01/2025 Earnings Call Q1 2025 Open →
  • 02/19/2025 Earnings Call Q4 2024 Open →
  • 10/29/2024 Earnings Call Q3 2024 Open →
  • 08/05/2024 Earnings Call Q2 2024 Open →
  • 04/24/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 09/15/2026 BIOMARIN PHARMACEUTICAL INC (BMRN): Other Events · sec.gov Open ↗
  • 09/14/2026 BIOMARIN PHARMACEUTICAL INC (BMRN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗
  • 09/01/2026 BIOMARIN PHARMACEUTICAL INC (BMRN): Other Events · sec.gov Open ↗
  • 08/31/2026 BIOMARIN PHARMACEUTICAL INC (BMRN): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/18/2026 BIOMARIN PHARMACEUTICAL INC (BMRN): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/06/2026 BIOMARIN PHARMACEUTICAL INC (BMRN): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?